XML 19 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9
3. EARNINGS PER SHARE
9 Months Ended
Feb. 28, 2015
Earnings Per Share [Abstract]  
3. EARNINGS PER SHARE

3.  EARNINGS PER SHARE

 

    Basic earnings per share is determined using the weighted average number of common shares outstanding during the period. Diluted earnings per share is determined using the weighted average number of common shares and potential common shares (representing the dilutive effect of stock options, and employee stock purchase plan shares) outstanding during the period using the treasury stock method.

 

    The following table presents the computation of basic and diluted net (loss) income per share attributable to Aehr Test Systems common shareholders (in thousands, except per share data):

 

 

    Three Months Ended     Nine Months Ended  
    February 28,     February 28,  
    2015     2014     2015     2014  
                         
Numerator: Net (loss) income   $ (1,726 )   $ 212     $ (4,747 )   $ 183  
                                 
Denominator for basic net (loss) income per share:                                
Weighted-average shares outstanding     12,677       10,982       11,931       10,807  
                                 
Shares used in basic net (loss) income per share calculation     12,677       10,982       11,931       10,807  
Effect of dilutive securities     --       1,295       --       776  
                                 
Denominator for diluted net (loss) income per share     12,677       12,277       11,931       11,583  
                                 
Basic net (loss) income per share   $ (0.14 )   $ 0.02     $ (0.40 )   $ 0.02  
                                 
Diluted net (loss) income per share   $ (0.14 )   $ 0.02     $ (0.40 )   $ 0.02  

 

    For the purpose of computing diluted earnings per share, weighted average potential common shares do not include stock options with an exercise price greater than the average fair value of the Company’s common stock for the period, as the effect would be anti-dilutive.  Stock options to purchase 3,402,000 shares of common stock and ESPP rights to purchase 175,000 ESPP shares were outstanding for the three months ending February 28, 2015, but were not included in the computation of diluted net loss per share, because the inclusion of such shares would be anti-dilutive.  Stock options to purchase 3,381,000 shares of common stock and ESPP rights to purchase 160,000 ESPP shares were outstanding for the nine months ending February 28, 2015, but were not included in the computation of diluted net loss per share, because the inclusion of such shares would be anti-dilutive.  In the three and nine months ended February 28, 2015, potential common shares have not been included in the calculation of diluted net loss per share as the effect would be anti-dilutive.  As such, the numerator and the denominator used in computing both basic and diluted net loss per share for these periods are the same.  Stock options to purchase 192,000 shares of common stock and ESPP rights to purchase 177,000 ESPP shares were outstanding for the three months ending February 28, 2014, but were not included in the computation of diluted net loss per share, because the inclusion of such shares would be anti-dilutive.  Stock options to purchase 370,000 shares of common stock and ESPP rights to purchase 177,000 ESPP shares were outstanding for the nine months ending February 28, 2014, but were not included in the computation of diluted net loss per share, because the inclusion of such shares would be anti-dilutive.